Those authors suggest that MIF acts as a mediator sustaining the inflammatory response in ARDS and that an anti-MIF strategy may represent a novel therapeutic approach in inflammatory diseases like ARDS. This evidence concerns the gene MIF and acute respiratory distress syndrome.